Senior insider sale
UNITED THERAPEUTICS CORP — senior position signals high conviction
$92.4K
224.00 shares
What this filing means
MESA NILDA plans to sell 224.00 shares of UNITED THERAPEUTICS CORP valued at approximately $92.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/8/2024ACC: 0001950047-24-008286
224.00
Shares to sell
$92.4K
Approx. market value
224.00
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock
Not Applicable
7/7/2023
224.00Total acquired224.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/7/2023 | Restricted Stock Not Applicable | 224.00 | — |
| Total | 224.00 | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
224.00
Market value
$92.4K
11/8/2024
Total
Units
224.00
Value
$92.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
11/8/2024 | 224.00 | $92.4K | NASDAQ | Planned |
| Total | 224.00 | $92.4K | ||